PCMI
BIOL

Princeton Capital Management Inc’s Biolase, Inc. BIOL Stock Holding History

Princeton Capital Management Inc’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$18K Sell
2
-8
-80% -$68.9K 0.01% 68
2017
Q2 		$117K Hold
10
– – 0.07% 65
2017
Q1 		$170K Hold
10
– – 0.11% 60
2016
Q4 		$176K Sell
10
-3
-23% -$59.3K 0.12% 61
2016
Q3 		$289K Sell
13
-11
-46% -$196K 0.19% 64
2016
Q2 		$352K Hold
24
– – 0.24% 62
2016
Q1 		$394K Sell
24
-3
-11% -$37.6K 0.27% 55
2015
Q4 		$288K Sell
27
-8
-23% -$87.4K 0.2% 57
2015
Q3 		$399K Hold
35
– – 0.24% 52
2015
Q2 		$771K Sell
35
-1
-3% -$24.4K 0.41% 45
2015
Q1 		$904K Sell
36
-1
-3% -$28.3K 0.46% 43
2014
Q4 		$1.2M Buy
37
+1
+3% +$31.3K 0.67% 42
2014
Q3 		$1.12M Hold
36
– – 0.72% 41
2014
Q2 		$992K Buy
36
+1
+3% +$25.5K 0.69% 46
2014
Q1 		$1.06M Buy
35
+1
+3% +$34.9K 0.77% 45
2013
Q4 		$1.21M Sell
34
-4
-11% -$94.8K 0.97% 38
2013
Q3 		$889K Sell
38
-1
-3% -$32.2K 0.81% 39
2013
Q2 		$1.71M Buy
+39
New +$2.18M 1.64% 26

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Princeton Capital Management Inc's BIOL Position: Q3 2017 in Review

Princeton Capital Management Inc reduced its Biolase, Inc. (BIOL) stake by 80% in Q3 2017, selling an estimated $68.9K and leaving 2 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #68.

Princeton Capital Management Inc first reported a position in BIOL in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.71M in Q2 2013. 28 funds tracked by Wall St. Rank hold BIOL as of Q3 2017.

  • Princeton Capital Management Inc held 2 shares of Biolase, Inc. worth $18K as of Q3 2017.
  • Princeton Capital Management Inc sold 8 Biolase, Inc. shares in Q3 2017, an estimated $68.9K.
  • Biolase, Inc. made up 0.01% of Princeton Capital Management Inc's portfolio in Q3 2017, its #68 holding.
  • Princeton Capital Management Inc first reported a position in Biolase, Inc. in Q2 2013 and has held it in 18 quarters since.
  • Princeton Capital Management Inc's Biolase, Inc. position peaked at $1.71M in Q2 2013.
  • 28 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2017.

Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.